Skip to content

Integra LifeSciences IART Short-Term Investments

Short-Term Investments at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$3M-81.3%
Stryker logo
StrykerSYK
$0
Axogen logo
AxogenAXGN
$18.95M+377%
Globus Medical logo
Globus MedicalGMED
$68.9M
Medtronic logo
MedtronicMDT
$7.27B+7.8%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$340.38M+22.8%

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B+53.4%
Enterprise value$3.12B+21.1%
P/S0.8×+0.3×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:ShortTermInvestments.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's short-term investments?
Integra LifeSciences (IART) reported short-term investments of $28.69M in Q1 2026.
How has Integra LifeSciences's short-term investments changed year-over-year?
Integra LifeSciences's short-term investments decreased by 16.1% year-over-year, from $34.19M to $28.69M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.